Bilal Ahmed Siddiqui, Mark N. Stein, Jingsong Zhang, Gerald Steven Falchook, Przemyslaw Twardowski, Xin Gao, Joseph W. Kim, Edward Paul Gelmann, Benedito A. Carneiro, David R. Wise, Benjamin Gartrell, I. Alex Bowman, Robert Dreicer, Shilpa Govindraj, Pradeep Thanigaimani, Fang Fang, Frank A. Seebach, Michael David Kinnaman, Sabina Sandigursky, Elizabeth Miller. "Nezastomig (anti-PSMA×CD28) with or without cemiplimab (anti–PD-1) in patients with metastatic castration-resistant prostate cancer (mCRPC) or metastatic clear cell renal cell carcinoma (mccRCC): A phase 1/2 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps296